New Malaria Antibody Drug Prevents Infection in Adults for 6 Months
Headline from The Buffalo News
TUESDAY, Nov. 1, 2022 (HealthDay News) -- A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where
The Buffalo News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
TUESDAY, Nov. 1, 2022 (HealthDay News) -- A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where
Research in Africa has found a one-time dose of an experimental drug protected adults against malaria for at least six months. The drug is a lab-made antibody. It works by
A trial in Mali showed for the first time that an antibody drug can be used to prevent malaria, a disease that kills more than half-a-million people each year.
One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found. The antibody was up to 88.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
New Malaria Antibody Drug Prevents Infection in Adults for 6 Months | Since Then
